Evidence-based testing for the detection and identification of infectious diseases
Mayo Clinic’s internationally renowned clinical microbiology laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases.
Our laboratories have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization, as well as provision treatment guidance for microbial pathogens.
Results that matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
tests performed annually
years of diagnosing and treating infectious diseases
specialized laboratories performing infectious disease testing
support from Mayo Clinic physicians and scientists
Physician-led subspecialized laboratories
Our laboratories are managed by physicians and scientists with expert knowledge regarding the clinical implications of each test result and how it can impact patient care.
The right tests, not the most tests
Our clinicians and laboratorians focus on maintaining high-quality, cost-effective, and efficient care by using algorithmic, evidence-based approaches that lead to correct diagnoses and treatment while minimizing unnecessary testing.
Every laboratory offers testing. But at Mayo Clinic Laboratories, in addition to our comprehensive testing menu, we offer a service that allow patients access to Mayo Clinic experts from across the world.
COVID-19 Resource Center
We are rapidly expanding our COVID-19 testing to provide accurate information for health care professionals on the front lines of this crisis. We will continue coordinating closely with state and federal officials to offer testing in the areas with the greatest need.
New research by Robin Patel, M.D. and others at Mayo Clinic has found that the use of a “transcriptomic-based cellular deconvolution tool” called CIBERSORTx could help improve the detection of infectious and non-infectious causes of failed joint replacement surgeries.
PACE / State of CA / State of FL
In this month’s “Virtual Lecture” Bobbi Pritt, M.D., shares a series of spooky tales to scare and amaze related to the discovery, characterization, and clinical presentation of notable viruses.
In this month's "Hot Topic," Robin Patel, M.D., discusses how the use of multiplex tests may reduce the turnaround time for identifying the cause of bloodstream infections, and how this might impact antibiotic stewardship and patient outcomes.
The field of clinical microbiology has a long and distinguished history at Mayo Clinic. Since the early 1900s, the clinical microbiology team has played important and leading roles in advancing testing and patient care.
Elitza Theel, Ph.D., director of the Infectious Diseases Serology Lab at Mayo Clinic, joins the "Answers From the Lab" podcast for a discussion with Bobbi Pritt, M.D. about tick-borne disease testing. In this episode, Dr. Theel and Dr. Pritt look at emerging tick-borne illnesses, the tests available to detect these infections, and how to prevent them.